The patent application No. 17/309,952 entitled “An A3 adenosine receptor ligand for use for achieving a fat loss effect”, has been accepted by the US Patent Office, will be issued on February ...

The US Patent Office has accepted patent application No 17/309,952, titled "An A3 adenosine receptor ligand for use for achieving a fat loss effect," which is supported by the data showing ...

The Namodenoson oral drug is well positioned in the field of anti-obesity agents due to its activity and favorable safety profile Ramat Gan, Israel, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Can-Fite ...

As reported by local NBC affiliate KSL, the United States Patent and Trademark Office refused the club’s attempt to trademark “Utah Yetis” earlier this month due to the prominence of another ...

Patent litigation reform could accelerate US biosimilar market entry, which lags behind the EU due to protracted legal processes. Biosimilar manufacturers face options like pre-clearance ...

US Patent Office patent No. 12088612, issued on September 10th 2024, outlines machine learning techniques that improve and optimise cyber inspection and protection operations initiated by various ...

U.S. trade officials will investigate alleged patent infringement by Chinese ... the Tariff Act of 1930 in the importation into the United States and sale of certain composite intermediate bulk ...

Newly published patents seem to show off the cooling system found inside the Nintendo Switch 2. The console was officially released this month and is scheduled for release sometime in 2025.

All of these commercial innovations and activities confirm de Soto’s insight that a “good legal property system is a medium that allows us to understand each other, make connections ...

(RTTNews) - Allurion Technologies, Inc. (ALUR) a Massachusetts-based medical device company Tuesday announced the issuance of a new U.S. patent for its advanced weight loss device to treat obesity ...